A pooled analysis of multicenter cohort studies of 123I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure

JACC: Cardiovascular Imaging

Volumn 6, Issue 7, 2013, Pages 772-784

  Nakata, Tomoaki ^a   Nakajima, Kenichi ^b   Yamashina, Shohei ^c   Yamada, Takahisa ^d   Momose, Mitsuru ^e   Kasama, Shu ^f   Matsui, Toshiki ^g   Matsuo, Shinro ^b   Travin, Mark I ^h   Jacobson, Arnold F ⁱ  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^d Osaka Prefectural General Medical Center   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f Cardiovascular Hospital of Central Japan   (Japan)

^g Japan   (Japan)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ GE HEALTHCARE   (United States)

Author keywords

cardiac sympathetic nerve function; heart failure; metaiodobenzylguanidine; pooled analysis; prognosis

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC IMAGING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TO MEDIASTINUM RATIO; HUMAN; HYPERTENSION; ISOTOPE LABELING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MEDICAL INFORMATION; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DATABASES AS TOPIC; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FEMALE; HEART; HEART FAILURE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RISK FACTORS; ROC CURVE; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84880008355     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.02.007     Document Type: Article

References (34)

1. J.N. Cohn, T.B. Levine, and M.T. Olivari Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823 (Pubitemid 14035089)
2. I.H. Zucker, K.P. Patel, and H.D. Schultz Neurohumoral stimulation Heart Fail Clin 8 2012 87 99
3. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J Am Coll Cardiol 54 2009 1747 1762
4. G. Eisenhofer, P. Friberg, and B. Rundqvist Cardiac sympathetic nerve function in congestive heart failure Circulation 93 1996 1667 1676 (Pubitemid 26131343)
5. D.M. Wieland, J.I. Wu, L.E. Brown, T.J. Mangner, D.P. Swanson, and W.H. Beierwaltes Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with 123 I-metaiodobenzylguanidine J Nucl Med 21 1980 349 353 (Pubitemid 10100562)
6. P. Merlet, J.L. Dubois-Rande, and S. Adnot Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy J Cardiovasc Pharmacol 19 1992 10 16
7. F.I. Parthenakis, V.K. Prassopoulos, and S.I. Koukouraki Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities J Nucl Cardiol 9 2002 15 22 (Pubitemid 34196226)
8. T. Nakata, K. Miyamoto, and A. Doi Cardiac death prediction and impaired cardiac sympathetic innervations assessed by metaiodobenzylguanidine in patients with failing and non-failing heart J Nucl Cardiol 5 1998 579 590 (Pubitemid 29015414)
9. K. Nakajima, J. Taki, N. Tonami, and K. Hisada Decreased 123 I-MIBG uptake and increased clearance in various cardiac diseases Nucl Med Commun 15 1994 317 323 (Pubitemid 24163899)
10. D. Agostini, H.J. Verberne, and W. Burchert I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study Eur J Nucl Med Mol Imaging 35 2008 535 546
11. A.F. Jacobson, R. Senior, and M.D. Cerqueira Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in chronic heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study J Am Coll Cardiol 55 2010 2212 2221
12. Y. Kuwahara, N. Tamaki, T. Nakata, S. Yamashina, and J. Yamazaki Determination of the survival rate in patients with congestive heart failure stratified by 123I-MIBG imaging: a meta-analysis from the studied performed in Japan Ann Nucl Med 25 2011 101 107
13. T. Wakabayashi, T. Nakata, and A. Hashimoto Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death J Nucl Med 42 2001 1757 1767 (Pubitemid 34016342)
14. M. Momose, H. Kobayashi, and N. Iguchi Comparison of parameters of 123I-mIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy Nucl Med Commun 20 1999 529 535 (Pubitemid 29509990)
15. J. Yamazaki, H. Muto, T. Kabano, S. Yamashina, S. Nanjo, and A. Inoue Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy - clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography Am Heart J 141 2001 645 652 (Pubitemid 32260734)
16. T. Matsui, T. Tsutamoto, K. Maeda, J. Kusukawa, and M. Kinoshita Prognostic value of repeated 123 I metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments - comparison with neurohumoral factors Circ J 66 2002 537 543 (Pubitemid 34733491)
17. S. Kasama, T. Toyama, and H. Kumakura Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure J Nucl Med 43 2002 1279 1285
18. T. Yamada, T. Shimonagata, and M. Fukunami Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study J Am Coll Cardiol 41 2003 231 238 (Pubitemid 36092191)
19. M. Kyuma, T. Nakata, and A. Hashimoto Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure J Nucl Med 45 2004 155 163 (Pubitemid 47628373)
20. JCS Joint Working Group Guidelines for clinical use of cardiac nuclear medicine (JCS 2010) - digest version - Circ J 76 2012 761 767
21. T. Nakata, K. Nagao, K. Tsuchihashi, A. Hashimoto, S. Tanaka, and O. Iimura Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine tomography in stable coronary artery disease Am J Cardiol 78 1996 292 297 (Pubitemid 26265270)
22. K. Sakata, M. Shirotani, H. Yoshida, and C. Kurata Iodide-123 metaiodobenzylguanidine cardiac imaging to identify and localize vasospastic angina without significant coronary artery narrowing J Am Coll Cardiol 30 1997 370 376 (Pubitemid 27339315)
23. D. Agostini, A. Belin, and M.H. Amar Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study J Nucl Med 41 2000 845 851 (Pubitemid 30266029)
24. T. Toyama, H. Hoshizaki, and R. Seki Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy J Nucl Med 44 2003 1604 1611 (Pubitemid 39663332)
25. T. Nakata, T. Wakabayashi, and M. Kyuma Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin- converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure Eur J Nucl Med Mol Imaging 32 2005 186 194 (Pubitemid 40248490)
26. A. Arora, K.J. Ferrick, and T. Nakata I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator J Nucl Cardiol 10 2003 121 131 (Pubitemid 36503797)
27. D. Nagahara, T. Nakata, and A. Hashimoto Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function J Nucl Med 49 2008 225 233 (Pubitemid 351225660)
28. K. Nishisato, A. Hashimoto, and T. Nakata Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs J Nucl Med 51 2010 1241 1249
29. H. Inoue, and D.P. Zipes Time course of denervation of efferent sympathetic and vagal nerves after occlusion of the coronary artery in the canine heart Circ Res 62 1988 1111 1120
30. A.E. Buxton, K.L. Lee, and G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157 (Pubitemid 47375017)
31. T. Doi, T. Nakata, and A. Hashimoto Cardiac mortality assessment improved by evaluation of cardiac sympathetic nerve activity in combination with hemoglobin and kidney function in chronic heart failure patients J Nucl Med 53 2012 731 740
32. M. Gheorghiade, G. Sopko, and L. De Luca Navigating the crossroads of coronary artery disease and heart failure Circulation 114 2006 1202 1213 (Pubitemid 44386485)
33. K. Nakajima, K. Matsubara, and T. Ishikawa Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio J Nucl Cardiol 14 2007 843 851 (Pubitemid 350082578)
34. H.J. Verberne, J.B.A. Habraken, B.L.F. van Eck-Smit, D. Agostini, and A.F. Jacobson Variations in 123I- metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardization and validation Eur J Nucl Med Mol Imaging 35 2008 547 553 (Pubitemid 351661673)